your shopping cart is empty.
arrowrightCONTACT
Choose your country Choose your country

Worldwide:
T: +49-30-6392-7878
X: +49-30-6392-7888

USA /Canada:
T: 1.888.578.2660
X: 1.888.578.2666

E-Mail:
peptide@jpt.com

Contact

Content follows

CATALOG PRODUCT FINDER

SpikeTides™ Set TAA - light

SpikeTides™ Set TAA - light

SpikeTides™ Set TAA - light
  
add to cart
 
 
 
Delivery in 2-5 days
121,80 €
121,80 €

Excluding tax
prices do not include tax. For shipment within Germany 19% MwSt will be included at checkout and in the invoice. For shipment within EU-countries you will need to provide the valid VAT number. International customers should note that all duties, import fees, and taxes are to be paid by the customer
and
shipping fees

SpikeTides™ Set TAA - light

Product Code: SPT-TAA

Collection of 252 representative proteotypic peptides for tumor associated antigens derived from 61 annotated human proteins for direct usage in mass-spectrometry based proteomics (MRM).
Amount: 3 x 96 well plate with 84 proteotypic peptides each (50-150 pmol per well)
Delivery Format: Three 96 well microtiter plates
Application(s): Cancer biomarker research, MRM assays, Proteomics, SRM assays, Mass spectrometry
Indication(s)/Topic(s): Gene regulation & expression, Cancer, Breast cancer, Burkitt's lymphoma, Gastric cancer, Testis/ovary cancer, Cancer chemotherapy, Melanoma, Prostate cancer
Delivery Time: 2-5 days

JPT's SpikeTides™ Sets TAA
JPT produced a set of proteotypic peptides for the detection of the most relevant tumor associated antigens (TAA) by mass-spectrometry based proteomics. 75 TAAs were selected and prioritized in a NCI pilot project to rank the most relevant cancer antigens to date (Cheever et al., 2009). For 61 of these TAAs JPT'synthesized proteotypic peptides with well documented MRM transition data available (www.srmatlas.org, ISB) resulting in a set of 252 proteotypic peptides for important tumor associated antigens. This set is available with light or isotopically labeled (C-terminal Arg U-13C6;U-15N4 or Lys U-13C6;U-15N2) peptides and is delivered in three 96 well plates.

Benefits of JPT's SpikeTides™ Sets TAA
- Relative quantification of multiple TAA’s from a single sample
- First economic heavy peptide set available
- Multiplexed analysis of disease status and therapeutic success

SpikeTides™ Set TAA - light

References:
Read References with Reference Peptides for Targeted Proteomics - SpikeTides™ & SpikeMix™

Application Notes
"Development of a Multiplexed Targeted SRM Assay for NCI’s Top Tumor Associated Antigens"
Soderblom et al., Application Note (2015)
Full text
"Absolute Quantification of Metabolic Enzymes via Targeted Proteomics using a new Kit of SpikeTides™ Peptides"
Bindel et al., Application Note (2015) Full text
"Development and Characterization of SpikeMix™ ABRF (cross-Species Standard) Consisting of 1,000 Stable Isotope Labeled Peptides"
Colangelo, Application Note (2014) Full text

Testimonials
"As Director of the Protein Profiling at Yale Keck Biotechnology Resource Facility, I coordinated a collaboration between the Association of Biomolecular Resource Facilities (ABRF) standard proteomic research group (sPRG) and JPT Peptide Technologies to develop the ABRF cross-species SpikeMix™ peptide pool. The joint development turned out to be an extraordinary effective endeavor and the resulting product was qualified in more than 52 proteomics labs around the globe. I was impressed by JPT's scientific and technological capabilities as well as their enthusiasm to drive the project forward."
Christopher M. Colangelo, Director of Protein Profiling at Keck Biotechnology Resource Facility, Yale University, USA

"Our research at Stanford University seeks to discover unconventional translation products, and proteins made by unsequenced organisms; to characterize a wide array of protein post-translational modifications; and to perform peptide antigen binding assays. On all of these fronts, we are in need of high quality peptide standards for assay development and protein quantification. The successful collaboration with the team at JPT Peptide Technologies and their wide range of products has been a critical factor for advancing my group's research."
Joshua E. Elias, Ph.D., Assistant Professor, Chemical & Systems Biology, Stanford University School of Medicine, Clark Center, Stanford, CA

SpikeTides™ Set TAA - light

 
Code
Product Name
 
Price
Buy
SPT-TAA-L
SpikeTides™ Set TAA - heavy
Collection of 252 representative isotopically labeled proteotypic peptides derived from 61 prioritized tumor associated antigens
add to cart
SPT-TAA-POOL
SpikeMix™ TAA - light
Pool of 252 representative proteotypic peptides for tumor associated antigens derived from 61 human cancer related proteins (e.g. MAGE, WT-1, ERBB2, p53, Myc). Peptide mixture f...
add to cart
SPT-TAA-POOL-L
SpikeMix™ TAA - heavy
Pool of 252 representative heavy isotope labeled proteotypic peptides for tumor associated antigens derived from 61 human cancer related proteins (e.g. MAGE, WT-1, ERBB2, p53, M...
add to cart
SPT-ABRF-POOL-L-1pm
SpikeMix™ ABRF (cross-species standard) - 1pmol
Pool of 1000 stable isotope-labeled proteotypic peptides from conserved human, mouse and rat proteins to be used as standard across the three species
add to cart
SPT-ABRF-POOL-L-10pm
SpikeMix™ ABRF (cross-species standard) - 10pmol
Pool of 1000 stable isotope-labeled proteotypic peptides from conserved human, mouse and rat proteins to be used as standard across the three species
add to cart

Description

Product Code: SPT-TAA

Collection of 252 representative proteotypic peptides for tumor associated antigens derived from 61 annotated human proteins for direct usage in mass-spectrometry based proteomics (MRM).
Amount: 3 x 96 well plate with 84 proteotypic peptides each (50-150 pmol per well)
Delivery Format: Three 96 well microtiter plates
Application(s): Cancer biomarker research, MRM assays, Proteomics, SRM assays, Mass spectrometry
Indication(s)/Topic(s): Gene regulation & expression, Cancer, Breast cancer, Burkitt's lymphoma, Gastric cancer, Testis/ovary cancer, Cancer chemotherapy, Melanoma, Prostate cancer
Delivery Time: 2-5 days

JPT's SpikeTides™ Sets TAA
JPT produced a set of proteotypic peptides for the detection of the most relevant tumor associated antigens (TAA) by mass-spectrometry based proteomics. 75 TAAs were selected and prioritized in a NCI pilot project to rank the most relevant cancer antigens to date (Cheever et al., 2009). For 61 of these TAAs JPT'synthesized proteotypic peptides with well documented MRM transition data available (www.srmatlas.org, ISB) resulting in a set of 252 proteotypic peptides for important tumor associated antigens. This set is available with light or isotopically labeled (C-terminal Arg U-13C6;U-15N4 or Lys U-13C6;U-15N2) peptides and is delivered in three 96 well plates.

Benefits of JPT's SpikeTides™ Sets TAA
- Relative quantification of multiple TAA’s from a single sample
- First economic heavy peptide set available
- Multiplexed analysis of disease status and therapeutic success

References

References:
Read References with Reference Peptides for Targeted Proteomics - SpikeTides™ & SpikeMix™

Application Notes
"Development of a Multiplexed Targeted SRM Assay for NCI’s Top Tumor Associated Antigens"
Soderblom et al., Application Note (2015)
Full text
"Absolute Quantification of Metabolic Enzymes via Targeted Proteomics using a new Kit of SpikeTides™ Peptides"
Bindel et al., Application Note (2015) Full text
"Development and Characterization of SpikeMix™ ABRF (cross-Species Standard) Consisting of 1,000 Stable Isotope Labeled Peptides"
Colangelo, Application Note (2014) Full text

Testimonials
"As Director of the Protein Profiling at Yale Keck Biotechnology Resource Facility, I coordinated a collaboration between the Association of Biomolecular Resource Facilities (ABRF) standard proteomic research group (sPRG) and JPT Peptide Technologies to develop the ABRF cross-species SpikeMix™ peptide pool. The joint development turned out to be an extraordinary effective endeavor and the resulting product was qualified in more than 52 proteomics labs around the globe. I was impressed by JPT's scientific and technological capabilities as well as their enthusiasm to drive the project forward."
Christopher M. Colangelo, Director of Protein Profiling at Keck Biotechnology Resource Facility, Yale University, USA

"Our research at Stanford University seeks to discover unconventional translation products, and proteins made by unsequenced organisms; to characterize a wide array of protein post-translational modifications; and to perform peptide antigen binding assays. On all of these fronts, we are in need of high quality peptide standards for assay development and protein quantification. The successful collaboration with the team at JPT Peptide Technologies and their wide range of products has been a critical factor for advancing my group's research."
Joshua E. Elias, Ph.D., Assistant Professor, Chemical & Systems Biology, Stanford University School of Medicine, Clark Center, Stanford, CA

Documentation

Properties

Related Products

SPT-TAA-L
SpikeTides™ Set TAA - heavy
Collection of 252 representative isotopically labeled proteotypic peptides derived from 61 prioritized tumor associated antigens
add to cart
SPT-TAA-POOL
SpikeMix™ TAA - light
Pool of 252 representative proteotypic peptides for tumor associated antigens derived from 61 human cancer related proteins (e.g. MAGE, WT-1, ERBB2, p53, Myc). Peptide mixture f...
add to cart
SPT-TAA-POOL-L
SpikeMix™ TAA - heavy
Pool of 252 representative heavy isotope labeled proteotypic peptides for tumor associated antigens derived from 61 human cancer related proteins (e.g. MAGE, WT-1, ERBB2, p53, M...
add to cart
SPT-ABRF-POOL-L-1pm
SpikeMix™ ABRF (cross-species standard) - 1pmol
Pool of 1000 stable isotope-labeled proteotypic peptides from conserved human, mouse and rat proteins to be used as standard across the three species
add to cart
SPT-ABRF-POOL-L-10pm
SpikeMix™ ABRF (cross-species standard) - 10pmol
Pool of 1000 stable isotope-labeled proteotypic peptides from conserved human, mouse and rat proteins to be used as standard across the three species
add to cart

News

> Read more news!

Quality Assurance

All production is performed according to ISO 9001:2015 standards.

ISO 9001

 
Stay in touch and be the first to receive the latest news!

Contact us:

JPT Peptide Technologies GmbH
Volmerstrasse 5
12489 Berlin, Germany
Technical Support:
T: +49-30-6392-7878
X: +49-30-6392-7888
e-mail: peptide@jpt.com
USA & Canada:
T: 1.888.JPT.COM0 (1.888.578.2660)
X: 1.888.JPT.COM6 (1.888.578.2666)
e-mail: peptide@jpt.com